118 related articles for article (PubMed ID: 35767882)
1. Upregulation of exonuclease 1 caused by homology-dependent repair confers cisplatin resistance to gastric cancer cells.
Mao P; Wu S; Fan Y
Can J Physiol Pharmacol; 2022 Sep; 100(9):903-914. PubMed ID: 35767882
[TBL] [Abstract][Full Text] [Related]
2. Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer.
He D; Li T; Sheng M; Yang B
Med Sci Monit; 2020 Mar; 26():e918751. PubMed ID: 32167078
[TBL] [Abstract][Full Text] [Related]
3. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
6. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.
Zhang Z; Yu X; Zhou B; Zhang J; Chang J
Biomed Res Int; 2020; 2020():5103272. PubMed ID: 32855967
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
[TBL] [Abstract][Full Text] [Related]
9. Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers.
Kamimura K; Suda T; Fukuhara Y; Okuda S; Watanabe Y; Yokoo T; Osaki A; Waguri N; Ishikawa T; Sato T; Aoyagi Y; Takamura M; Wakai T; Terai S
Sci Rep; 2021 Mar; 11(1):6255. PubMed ID: 33737617
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
11. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.
Park J; Ko YS; Yoon J; Kim MA; Park JW; Kim WH; Choi Y; Kim JH; Cheon Y; Lee BL
Gastric Cancer; 2014; 17(3):423-30. PubMed ID: 24202965
[TBL] [Abstract][Full Text] [Related]
12. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.
Li H; Ma X; Yang D; Suo Z; Dai R; Liu C
J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
[TBL] [Abstract][Full Text] [Related]
14. Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
Yu HE; Wang F; Yu F; Zeng ZL; Wang Y; Lu YX; Jin Y; Wang DS; Qiu MZ; Pu HY; Kang TB; Xie D; Ju HQ; Xu RH; Luo HY
Cell Death Dis; 2019 May; 10(6):413. PubMed ID: 31138787
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
16. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
Song C; Duan C
Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
[TBL] [Abstract][Full Text] [Related]
18. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
[TBL] [Abstract][Full Text] [Related]
19. DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network.
Karanja KK; Cox SW; Duxin JP; Stewart SA; Campbell JL
Cell Cycle; 2012 Nov; 11(21):3983-96. PubMed ID: 22987153
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
Zhang J; Zha W; Qian C; Ding A; Mao Z
Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
